Association between continuous device-based physical activity monitoring over six months and cardiorespiratory, metabolic and body composition outcomes in post-surgery cancer survivors - An observational cohort analysis within a randomized controlled trial (CRBP-TS Study)

连续六个月基于设备的身体活动监测与癌症术后幸存者的心肺、代谢和身体成分结果之间的关联——一项随机对照试验中的观察性队列分析(CRBP-TS 研究)

阅读:1

Abstract

BACKGROUND: The current guidelines for physical activity often rely on self-reported data or short-term activity tracking. We aimed to explore device-based long-term physical activity tracking and its possible association with cancer survivors' cardiorespiratory fitness (CRF), metabolic health, and body composition. METHODS: In this observational analysis of a randomized controlled trial (CRBP-TS study), we reanalyzed data from 111 patients with breast, prostate, and colorectal cancer. Dependent variables included cardiorespiratory outcomes, body composition, metabolic biomarkers, and fatigue. A multiple linear regression model was used to analyze the data, considering age, gender, BMI, and baseline values. A consumer wearable device measured moderate-to-vigorous physical activity (MVPA) and steps continuously over six months, ensuring a detailed and accurate record of the participants' daily physical activity. RESULTS: Physical activity data from all participants indicated a mean of moderate physical activity 108 min/wk (SD ± 88), vigorous physical activity 41 min/wk (SD ± 36), and 8498 steps/day (SD ± 2490). We observed that higher levels of MVPA were significantly associated with higher maximum oxygen uptake (VO(2max); β = 0.5, 95% CI [0.02 to 1.0], p = 0.042), higher peak power output (PPO; β = 0.04, 95% CI [0.003 to 0.08], p = 0.037), and higher cardiac output (β = 0.6, 95% CI [0.2 to 1.1], p = 0.009). Additionally, more steps correlated significantly with higher VO(2max) (β = 0.27, 95% CI [0.04 to 0.51], p = 0.023), higher cardiac output (β = 0.2, 95% CI [0.013 to 0.47], p = 0.039), lower fat mass (β= -0.24, 95% CI [-0.44 to 0.03], p = 0.028), lower insulin (β=-4.2, 95% CI [-6.4 to -2.0], p < 0.000), and lower leptin (β=-0.56, 95% CI [-0.97 to -0.15], p = 0.008). CONCLUSIONS: Continuous activity tracking with wearable devices provides an objective and standardized opportunity to investigate the amount of aerobic physical activity and its association with systemic health outcomes in cancer survivors. Our long-term activity data support a positive relationship between aerobic physical activity and cardiorespiratory fitness as well as metabolic health. TRIAL REGISTRATION: DRKS-ID: DRKS00020499; Registered 17 March 2020, https://drks.de/search/en/trial/DRKS00020499 .

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。